Results 11 to 20 of about 420,437 (312)

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells [PDF]

open access: yesTumor Biology, 2017
Recurrence of breast cancer after radiotherapy may be partly explained by the presence of radioresistant cells. Thus, it would be desirable to develop an effective therapy against radioresistant cells. In this study, we demonstrated the intense antitumor
Qingming Guo   +8 more
doaj   +4 more sources

Cytokine-Induced Killer Cells [PDF]

open access: yesDefinitions, 2020
A preparation of autologous lymphocytes with potential immunopotentiating and antineoplastic activities. Cytokine-induced killer (CIK) cells are CD3and CD56-positive, non-major histocompatibility complex (MHC)-restricted, natural killer (NK)-like T ...

semanticscholar   +2 more sources

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma. [PDF]

open access: yesCancers (Basel), 2020
Simple Summary Cytokine-induced killer (CIK) cells are a heterogeneous population of polyclonal T effector cells expanded ex vivo. Here, we updated our last review published in 2012 and provided a synopsis of current 15 clinical studies, including 382 ...
Zhang Y   +3 more
europepmc   +2 more sources

Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70 [PDF]

open access: yesNature Communications, 2018
Invariant natural killer T (iNKT) cells can be subsetted based on their cytokine productions. Here the authors show, using Zap70 mutant mice, that interferon-γ secreting (IFN-γ) iNKT cells may be induced by hampered T cell receptor signallings to help ...
Meng Zhao   +10 more
doaj   +5 more sources

ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma. [PDF]

open access: yesFront Immunol, 2020
High-risk rhabdomyosarcoma (RMS) occurring in childhood to young adulthood is associated with a poor prognosis; especially children above the age of 10 with advanced stage alveolar RMS still succumb to the disease within a median of 2 years.
Merker M   +11 more
europepmc   +2 more sources

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer. [PDF]

open access: yesInt J Mol Sci, 2020
Cytokine-induced killer (CIK) cells are heterogeneous, major histocompatibility complex (MHC)-unrestricted T lymphocytes that have acquired the expression of several natural killer (NK) cell surface markers following the addition of interferon gamma (IFN-
Dehno MN   +3 more
europepmc   +2 more sources

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. [PDF]

open access: yesWorld J Gastroenterol, 2019
BACKGROUND Hepatocellular carcinoma (HCC) has been revealed as the second most common cause of cancer-related deaths worldwide. The introduction of cell-based immunotherapy, including dendritic cells (DCs) and cytokine-induced killer cells (CIKs), has ...
Cao J, Kong FH, Liu X, Wang XB.
europepmc   +2 more sources

Autologous Cytokine-induced Killer Cells [PDF]

open access: yesDefinitions, 2020
A proprietary formulation of autologous cytokine-induced killer (CIK) T -lymphocytes, with immunopotentiating and antineoplastic activities. T hese CIK cells are generated by ex vivo incubation of autologous peripheral blood lymphocytes with an ...

semanticscholar   +2 more sources

Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells [PDF]

open access: yesJournal of Immunology Research, 2016
Adoptive cell therapy (ACT) using autologous cytokine-induced killer (CIK) cells is a promising treatment for metastatic carcinomas. In this study, we investigated the impact of RetroNectin on the proliferation, phenotype alternation, cytokine secretion,
Lu Han   +3 more
doaj   +3 more sources

Cytokine Induced Killer (CIK) Cells Based Adoptive Immunotherapy

open access: yesJournal of Gandaki Medical College, 2018
Cytokine induced killer (CIK) cells has been increasingly used in adoptive immunotherapy against various cancers and viral infections. This review summarizes the basic overview of CIK cells as a therapeutic immunocyte.
S Timalsena, P P Lamichhane
doaj   +3 more sources

Home - About - Disclaimer - Privacy